Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A I Woods

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Thrombosis Research|August 1, 1987
Aspirin effect on platelet antiplasmins releaseA I Woods, M A Lazzari
Thrombosis Research|October 15, 1988
Aspirin effect on the release of plasminogen activator inhibitors by human plateletsA I Woods, M A Lazzari
Hematology (Amsterdam, Netherlands)|April 18, 2012
Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosisM A Lazzari, A Sanchez-Luceros, A I Woods, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
von Willebrand's disease diagnosis and laboratory issuesG Castaman, R R Montgomery, S S Meschengieser, et al.
American Journal of Clinical Pathology|March 17, 1999
Binding of von Willebrand factor to collagen by flow cytometryA C Kempfer, M R Silaf, C E Farias, et al.
Haematologica|April 28, 2001
Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's diseaseA I Woods, S S Meschengieser, A N Blanco, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 20, 2011
C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significanceA I Woods, A Sanchez-Luceros, A C Kempfer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Thrombosis Research|August 1, 1987
Aspirin effect on platelet antiplasmins releaseA I Woods, M A Lazzari
Thrombosis Research|October 15, 1988
Aspirin effect on the release of plasminogen activator inhibitors by human plateletsA I Woods, M A Lazzari
Hematology (Amsterdam, Netherlands)|April 18, 2012
Von Willebrand factor (VWF) as a risk factor for bleeding and thrombosisM A Lazzari, A Sanchez-Luceros, A I Woods, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 2, 2010
von Willebrand's disease diagnosis and laboratory issuesG Castaman, R R Montgomery, S S Meschengieser, et al.
American Journal of Clinical Pathology|March 17, 1999
Binding of von Willebrand factor to collagen by flow cytometryA C Kempfer, M R Silaf, C E Farias, et al.
Haematologica|April 28, 2001
Clinical features and laboratory patterns in a cohort of consecutive Argentinian patients with von Willebrand's diseaseA I Woods, S S Meschengieser, A N Blanco, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 20, 2011
C1272F: a novel type 2A von Willebrand's disease mutation in A1 domain; its clinical significanceA I Woods, A Sanchez-Luceros, A C Kempfer, et al.
Pageof 1